New form of cellular immunotherapy shows promise against brain tumors in mice

Scientists from the German Cancer Research Center (DKFZ) and the University Medical Center Mannheim (UMM) successfully tested a new form of cellular immunotherapy against brain tumors in mice for the first time.

New psychological treatment for epileptic children lowers mental health problems

A new psychological treatment for children with epilepsy, developed by a UCL-led team of scientists, has been shown to reduce mental health difficulties compared to

March 8, 2024

Personalized brain circuit scores define six depression and anxiety biotypes

Researchers used functional magnetic resonance imaging data on brain circuit function to derive interpretable, personalized brain circuit dysfunction scores for patients with anxiety and depression.

June 19, 2024

Boehringer Ingelheim, Eli Lilly’s Jardiance nabs approval in Europe for chronic kidney disease

Boehringer Ingelheim and Eli Lilly said Jardiance received approval in Europe as a treatment for chronic kidney disease in adults, with the FDA’s decision on

July 26, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.